We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

45 hedge funds and large institutions have $50.4M invested in InVivo Therapeutics Holdings Corp in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

13% more capital invested

Capital invested by funds: $44.5M → $50.4M (+$5.97M)

2% more funds holding

Funds holding: 44 → 45 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

64% less call options, than puts

Call options by funds: $255K | Put options by funds: $712K

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
8
Reduced
5
Closed
3
Calls
$255K
Puts
$712K
Net Calls
-$457K
Net Calls Change
-$1.53M

Top Buyers

Rank Fund Capital Flow
1
GC
Guggenheim Capital
Illinois
+$1.12M
2
ICM
IMS Capital Management
Oregon
+$749K
3
TI
Turner Investments
Pennsylvania
+$624K
4
BFA
BlackRock Fund Advisors
California
+$374K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$374K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$3.87M
2
Goldman Sachs
Goldman Sachs
New York
-$873K
3
CS
Credit Suisse
Switzerland
-$125K
4
CG
Cutler Group
California
-$125K
5
LPL Financial
LPL Financial
California
-$125K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
$21K – – –
EWM
52
Edge Wealth Management
New York
$20K – – –
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$16.1K – – –
BlackRock
54
BlackRock
New York
$15K – – –
IA
55
IFP Advisors
Florida
$9K – – –
AIM
56
Advantage Investment Management
Iowa
$7K – – –
JCM
57
Jacobi Capital Management
Pennsylvania
$3K – – –
FNBT
58
FineMark National Bank & Trust
Florida
$2K – – –
PNC Financial Services Group
59
PNC Financial Services Group
Pennsylvania
$2K – – –
Royal Bank of Canada
60
Royal Bank of Canada
Ontario, Canada
$1K – – –
SEI Investments
61
SEI Investments
Pennsylvania
$1K – – –
TCIM
62
TIAA CREF Investment Management
New York
$691 – – –
VOYA Investment Management
63
VOYA Investment Management
Georgia
$99 – – –
SM
64
Sabby Management
Florida
– -$3.87M -31 Closed
CG
65
Cutler Group
California
– -$125K -1 Closed
HCM
66
Highbridge Capital Management
New York
– -$74K -1 Closed
TRCT
67
Tower Research Capital (TRC)
New York
– -$28K – –
1 2
3

NVIV Hedge Fund Activity: Q3 2016 in Review

45 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q3 2016, worth a combined $50.4M — up 13% from $44.5M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NVIV positions and 3 closed out — a net gain of 1 holder — while 8 added to existing stakes and 5 trimmed.

The largest buyer was Guggenheim Capital, opening a new position worth an estimated $1.12M. The largest seller was Sabby Management, exiting entirely with an estimated $3.87M sold.

  • 45 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q3 2016, up from 44 in Q2 2016.
  • Funds reported $50.4M of InVivo Therapeutics Holdings Corp stock for Q3 2016, up 13% quarter-over-quarter.
  • 4 funds opened new InVivo Therapeutics Holdings Corp positions in Q3 2016 and 3 closed out, a net change of +1 holder.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q3 2016 was Guggenheim Capital, an estimated $1.12M added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q3 2016 was Sabby Management, an estimated $3.87M sold.

Based on aggregated 13F filings for Q3 2016.